APO-LORAZEPAM
APO-LORAZEPAM
Approved
DIN Number
00655759
Drug Class
Human
Market Date
Dec 31, 1985
Company
HC
Apotex Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00655759
AIG Number0110731001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA06 LORAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
LORAZEPAMActive
Strength: 1 MG
Monograph: LORAZEPAM